Skip to main content
Premium Trial:

Request an Annual Quote

Physiomics to Use Simulation Software to Select Targets for Cronos

NEW YORK, Nov. 24 (GenomeWeb News) - Physiomics will select drug targets for Cronos Therapeutics using its cell cycle simulation software, the UK-based companies said yesterday.

 

Physiomics, located in Oxford, will use its mammalian cell cycle model, which is linked to PK-Sim drug delivery software from Bayer Technology Services in Germany, to select the best targets for Cronos' GeneICE gene silencing technology.

 

GeneICE prevents transcription by using cellular gene repressor complexes that interact with the target gene and modify its chromatin structure.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.